APA

Cao Z., Wang X., Lu L., Xu J., Li X., Zhang G., Ma Z., Shi A., Wang Y. & Song Y. (2018). β-Sitosterol and Gemcitabine Exhibit Synergistic Anti-pancreatic Cancer Activity by Modulating Apoptosis and Inhibiting Epithelial-Mesenchymal Transition by Deactivating Akt/GSK-3β Signaling. : Frontiers in pharmacology.

Chicago

Cao Zhang-Qi, Wang Xue-Xi, Lu Li, Xu Jing-Wen, Li Xiao-Bin, Zhang Guang-Ru, Ma Zhan-Jun, Shi An-Chen, Wang Yan and Song Yu-Jun. 2018. β-Sitosterol and Gemcitabine Exhibit Synergistic Anti-pancreatic Cancer Activity by Modulating Apoptosis and Inhibiting Epithelial-Mesenchymal Transition by Deactivating Akt/GSK-3β Signaling. : Frontiers in pharmacology.

Harvard

Cao Z., Wang X., Lu L., Xu J., Li X., Zhang G., Ma Z., Shi A., Wang Y. and Song Y. (2018). β-Sitosterol and Gemcitabine Exhibit Synergistic Anti-pancreatic Cancer Activity by Modulating Apoptosis and Inhibiting Epithelial-Mesenchymal Transition by Deactivating Akt/GSK-3β Signaling. : Frontiers in pharmacology.

MLA

Cao Zhang-Qi, Wang Xue-Xi, Lu Li, Xu Jing-Wen, Li Xiao-Bin, Zhang Guang-Ru, Ma Zhan-Jun, Shi An-Chen, Wang Yan and Song Yu-Jun. β-Sitosterol and Gemcitabine Exhibit Synergistic Anti-pancreatic Cancer Activity by Modulating Apoptosis and Inhibiting Epithelial-Mesenchymal Transition by Deactivating Akt/GSK-3β Signaling. : Frontiers in pharmacology. 2018.